Doctor WhoWHO · #377 · 2023 · Nonfoil and foilOpen exact printing $0.51ConfidenceLow ConfidenceView set
Marketplace Comparison
Compare source coverage
Marketplace prices may represent different finish or condition coverage. Check the source listing before comparing.
Source prices are 1.75x apart.
Supply
Supply and condition coverage
Inventory is not tracked for this exact printing yet.
NM, LP/SP, and MP/HP tracked. Seller and listing counts are tracked for the print overall, not separately by finish or condition.
Exact-print history
Price & inventory history
Price and inventory history for this printing may combine available finishes.
Other printings
Other printings
Prices, supply, and confidence can differ substantially by exact version.
Doctor WhoWHO · #377 · 2023 · Nonfoil and foilOpen exact printing $0.51ConfidenceLow ConfidenceView set
Doctor WhoWHO · #968 · 2023 · FoilOpen exact printing $2.27ConfidenceLow ConfidencePremium treatmentView set
Doctor WhoWHO · #74 · 2023 · Nonfoil and foilOpen exact printing $0.34ConfidenceOutlier RiskView setAdvanced market dataOpen
Detailed metrics
- NeoScore
- 10 F Tier
- Organic demand
- 0 Thin organic demand
Card rules & legalityOpen
Deal with the Black Guardian — When Vislor Turlough enters, you may have an opponent gain control of it. If you do, it's goaded for as long as they control it. At the beginning of your end step, draw a card, then you lose life equal to the number of cards in your hand. Doctor's companion (You can have two commanders if the other is the Doctor.)
- Mana cost
- {3}{B}
- Color identity
- B
- Reserved List
- No
- Released
- Oct 13, 2023
- Legal formats
- Duel, Legacy, Vintage, Commander, Oathbreaker
Sources, methodology, and disclosureOpen
NeoPrice and Pricing Confidence use the existing NeoCardAlpha methodology. CardTrader is the inventory source, TCGplayer is the primary pricing source, and Card Kingdom is validation-only.
NeoCardAlpha may earn a commission from certain marketplace links.
Card Kingdom retail validation is visible when a matching product is available, but it remains a validation source.
